New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
08:47 EDTEPZMEpizyme price target raised to $52 from $37 at Wedbush
Wedbush increased its price target on Epizyme after the company released clinical data on its EPZ-5676 treatment that the firm views as positive. The firm reiterates an Outperform rating on the stock.
News For EPZM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 8, 2014
13:32 EDTEPZMEpizyme announces results for PRMT5 inhibitor
Subscribe for More Information
December 7, 2014
14:23 EDTEPZMEpizyme to hold a luncheon discussion
Subscribe for More Information
December 4, 2014
12:58 EDTEPZMPRIMECAP Management reports 8.47% passive stake in Epizyme
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use